ARTICLE | Company News
Ablexis, J&J deal
February 24, 2017 9:33 PM UTC
Ablexis granted Johnson & Johnson’s Janssen Biotech Inc. unit perpetual, non-exclusive rights to use Ablexis' AlivaMab Mouse transgenic mouse platform for antibody drug discovery and development. Able...